Jefferies Group's MIRM Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 8,500 shares of Mirum Pharmaceuticals, Inc. (MIRM) worth $785,230, representing 0.01% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 6 quarters.
Based on 13F filings, Jefferies Group has maintained this position in MIRM for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 23,500 shares. Largest reduction occurred in Q2 2025, reducing 23,500 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Mirum Pharmaceuticals (MIRM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Mirum Pharmaceuticals (MIRM) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +8,500 | New Buy | 8,500 | $92.38 |
| Q2 2025 | -23,500 | Sold Out | 0 | $0.00 |
| Q1 2025 | +23,500 | New Buy | 23,500 | $45.05 |
| Q3 2024 | -8,900 | Sold Out | 0 | $0.00 |
| Q2 2024 | -430 | Reduce 4.61% | 8,900 | $34.19 |
| Q1 2024 | +9,330 | New Buy | 9,330 | $25.12 |
Jefferies Group's Mirum Pharmaceuticals Investment FAQs
Jefferies Group first purchased Mirum Pharmaceuticals, Inc. (MIRM) in Q1 2024, acquiring 9,330 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Mirum Pharmaceuticals, Inc. (MIRM) for 6 quarters since Q1 2024.
Jefferies Group's largest addition to Mirum Pharmaceuticals, Inc. (MIRM) was in Q1 2025, adding 23,500 shares worth $1.06 M.
According to the latest 13F filing for Q1 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 8,500 shares of Mirum Pharmaceuticals, Inc. (MIRM), valued at approximately $785,230.
As of the Q1 2026 filing, Mirum Pharmaceuticals, Inc. (MIRM) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Mirum Pharmaceuticals, Inc. (MIRM) was 23,500 shares, as reported at the end of Q1 2025.